Literature DB >> 8393665

Hepatocyte heterogeneity in response to extracellular adenosine.

Y Morimoto1, M Wettstein, D Häussinger.   

Abstract

Metabolic and haemodynamic effects of adenosine were studied in antegrade and retrograde rat liver perfusions with influent nucleoside concentrations either below (i.e. 20 microM) or exceeding (i.e. 200-300 microM) the single-pass clearance capacity of the liver. Adenosine (20 microM) increased in antegrade perfusions the perfusion pressure and markedly stimulated prostaglandin D2, thromboxane B2 and glucose output, whereas in retrograde perfusions no pressure and eicosanoid response occurred and glucose output was stimulated only slightly. The perfusion-direction-dependent differences in the glucose and pressure response to adenosine (20 microM) were fully abolished in presence of ibuprofen (50 microM). When the adenosine concentration in influent was raised to 200-300 microM, i.e. to a concentration exceeding single-pass clearance of the nucleoside, the adenosine-induced prostaglandin D2 release was about 10-fold higher in retrograde perfusions than in antegrade perfusions. On the other hand, both adenosine (20-300 microM)-induced cyclic AMP (cAMP) and K+ release from the liver were not affected by the direction of perfusion, and maximal effects on cAMP release were observed at influent adenosine concentrations of 100 microM. The basal rate (adenosine absent) of prostaglandin D2 and thromboxane B2 release was about 10-fold higher in retrograde than in antegrade perfusion experiments, whereas the basal cAMP release from the liver was not affected by the direction of perfusion. Maximal adenosine-stimulated glucose output was significantly higher in antegrade than in retrograde perfusions at all adenosine concentrations tested (range 10-300 microM). Ibuprofen abolished this difference, indicating that eicosanoids liberated under the influence of adenosine contribute to the glycogenolytic response in antegrade, but not in retrograde, perfusion. Desensitization occurred following repetitive adenosine infusion; this was more pronounced for adenosine-induced prostaglandin release than for cAMP or K+ efflux. The data suggest the following. (i) Both cAMP and eicosanoids are involved in the stimulation of glycogenolysis by adenosine. (ii) Eicosanoids are probably liberated under the influence of extracellular adenosine from a portal pre-sinusoidal compartment and accordingly stimulate glycogenolysis only in antegrade perfusions. Thus signals derived from portal vein structures can modulate hepatocellular function. (iii) Contractile elements are probably located also inside the liver acinus. (iv) Eicosanoids released into the hepatic vein reflect less than 10% of hepatic eicosanoid formation, because of marked clearance by perivenous hepatocytes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8393665      PMCID: PMC1134400          DOI: 10.1042/bj2930573

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  31 in total

1.  Glycogenolytic and haemodynamic responses to heat-aggregated immunoglobulin G and prostaglandin E2 in the perfused rat liver.

Authors:  D B Buxton; R A Fisher; D L Briseno; D J Hanahan; M S Olson
Journal:  Biochem J       Date:  1987-04-15       Impact factor: 3.857

Review 2.  Purine receptors in mammalian tissues: pharmacology and functional significance.

Authors:  M Williams
Journal:  Annu Rev Pharmacol Toxicol       Date:  1987       Impact factor: 13.820

3.  The ability of adenosine to decrease the concentration of fructose 2,6-bisphosphate in isolated hepatocytes. A cyclic AMP-mediated effect.

Authors:  R Bartrons; E Van Schaftingen; H G Hers
Journal:  Biochem J       Date:  1984-02-15       Impact factor: 3.857

4.  The use of perfusion of liver and other organs for the study of microsomal electron-transport and cytochrome P-450 systems.

Authors:  H Sies
Journal:  Methods Enzymol       Date:  1978       Impact factor: 1.600

5.  Subclasses of external adenosine receptors.

Authors:  C Londos; D M Cooper; J Wolff
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

6.  Effects of adenosine and adenosine analogues on glycogen metabolism in isolated rat hepatocytes.

Authors:  L J Hoffer; J M Lowenstein
Journal:  Biochem Pharmacol       Date:  1986-12-15       Impact factor: 5.858

7.  Stimulation of glycogenolysis in isolated hepatocytes by adenosine and one of its analogues is inhibited by caffeine.

Authors:  J C Stanley; J Markovic; A M Gutknecht; F J Lozeman
Journal:  Biochem J       Date:  1987-11-01       Impact factor: 3.857

8.  Metabolism of prostaglandins D2 and F2 alpha in primary cultures of rat hepatocytes.

Authors:  T Sago; R Nakayama; T Okumura; K Saito
Journal:  Biochim Biophys Acta       Date:  1986-12-05

Review 9.  Eicosanoids, signal molecules of liver cells.

Authors:  K Decker
Journal:  Semin Liver Dis       Date:  1985-05       Impact factor: 6.115

10.  Degradation of prostaglandin E2 in a primary culture of adult rat hepatocytes.

Authors:  T Okumura; K Saito
Journal:  J Biochem       Date:  1984-08       Impact factor: 3.387

View more
  8 in total

1.  A distinct nitric oxide and adenosine A1 receptor dependent hepatic artery vasodilatatory response in the CCl-cirrhotic liver.

Authors:  Alexander Zipprich; Wajahat Z Mehal; Cristina Ripoll; Roberto J Groszmann
Journal:  Liver Int       Date:  2010-05-24       Impact factor: 5.828

2.  Regional heterogeneities in the production of uric acid from adenosine in the bivascularly perfused rat liver.

Authors:  T R Fernandes; F Suzuki-Kemmelmeier; E L Ishii-Iwamoto; J Constantin; A Bracht
Journal:  Mol Cell Biochem       Date:  1999-05       Impact factor: 3.396

3.  Nonparenchymal cell and hepatocellular injury to human liver grafts assessed by enzyme-release into the perfusate.

Authors:  U Rauen; J Erhard; P Kühnhenrich; R Lange; M Moissidis; F W Eigler; H de Groot
Journal:  Langenbecks Arch Chir       Date:  1994

4.  Hepatic heterogeneity in the response to ATP studied in the bivascularly perfused rat liver.

Authors:  V C Minguetti-Câmara; J Constantin; F Suzuki-Kemmelmeier; E L Ishii-Iwamoto; A Bracht
Journal:  Mol Cell Biochem       Date:  1998-02       Impact factor: 3.396

5.  The action of extracellular NAD+ on gluconeogenesis in the perfused rat liver.

Authors:  Adriana G Martins; Jorgete Constantin; Fabrício Bracht; Ana Maria Kelmer-Bracht; Adelar Bracht
Journal:  Mol Cell Biochem       Date:  2006-04-21       Impact factor: 3.396

6.  Adenosine induces loss of actin stress fibers and inhibits contraction in hepatic stellate cells via Rho inhibition.

Authors:  Muhammad A Sohail; Ardeshir Z Hashmi; Wyel Hakim; Azuma Watanabe; Alexander Zipprich; Roberto J Groszmann; Jonathan A Dranoff; Natalie J Torok; Wajahat Z Mehal
Journal:  Hepatology       Date:  2009-01       Impact factor: 17.425

7.  Heterogenic response of the liver parenchyma to ethanol studied in the bivascularly perfused rat liver.

Authors:  Carlos Henrique Lopez; Jorgete Constantin; Daniele Gimenes; Fumie Suzuki-Kemmelmeier; Adelar Bracht
Journal:  Mol Cell Biochem       Date:  2004-03       Impact factor: 3.396

Review 8.  Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.

Authors:  Patricio Godoy; Nicola J Hewitt; Ute Albrecht; Melvin E Andersen; Nariman Ansari; Sudin Bhattacharya; Johannes Georg Bode; Jennifer Bolleyn; Christoph Borner; Jan Böttger; Albert Braeuning; Robert A Budinsky; Britta Burkhardt; Neil R Cameron; Giovanni Camussi; Chong-Su Cho; Yun-Jaie Choi; J Craig Rowlands; Uta Dahmen; Georg Damm; Olaf Dirsch; María Teresa Donato; Jian Dong; Steven Dooley; Dirk Drasdo; Rowena Eakins; Karine Sá Ferreira; Valentina Fonsato; Joanna Fraczek; Rolf Gebhardt; Andrew Gibson; Matthias Glanemann; Chris E P Goldring; María José Gómez-Lechón; Geny M M Groothuis; Lena Gustavsson; Christelle Guyot; David Hallifax; Seddik Hammad; Adam Hayward; Dieter Häussinger; Claus Hellerbrand; Philip Hewitt; Stefan Hoehme; Hermann-Georg Holzhütter; J Brian Houston; Jens Hrach; Kiyomi Ito; Hartmut Jaeschke; Verena Keitel; Jens M Kelm; B Kevin Park; Claus Kordes; Gerd A Kullak-Ublick; Edward L LeCluyse; Peng Lu; Jennifer Luebke-Wheeler; Anna Lutz; Daniel J Maltman; Madlen Matz-Soja; Patrick McMullen; Irmgard Merfort; Simon Messner; Christoph Meyer; Jessica Mwinyi; Dean J Naisbitt; Andreas K Nussler; Peter Olinga; Francesco Pampaloni; Jingbo Pi; Linda Pluta; Stefan A Przyborski; Anup Ramachandran; Vera Rogiers; Cliff Rowe; Celine Schelcher; Kathrin Schmich; Michael Schwarz; Bijay Singh; Ernst H K Stelzer; Bruno Stieger; Regina Stöber; Yuichi Sugiyama; Ciro Tetta; Wolfgang E Thasler; Tamara Vanhaecke; Mathieu Vinken; Thomas S Weiss; Agata Widera; Courtney G Woods; Jinghai James Xu; Kathy M Yarborough; Jan G Hengstler
Journal:  Arch Toxicol       Date:  2013-08-23       Impact factor: 5.153

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.